Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Safety and tolerability of nintedanib for the treatment of idiopathic pulmonary fibrosis in routine UK clinical practice.

Fletcher SV, Jones MG, Renzoni EA, Parfrey H, Hoyles RK, Spinks K, Kokosi M, Kwok A, Warburton C, Titmuss V, Thillai M, Simler N, Maher TM, Brereton CJ, Chua F, Wells AU, Richeldi L, Spencer LG.

ERJ Open Res. 2018 Oct 19;4(4). pii: 00049-2018. doi: 10.1183/23120541.00049-2018. eCollection 2018 Oct.

2.

Nanoscale dysregulation of collagen structure-function disrupts mechano-homeostasis and mediates pulmonary fibrosis.

Jones MG, Andriotis OG, Roberts JJ, Lunn K, Tear VJ, Cao L, Ask K, Smart DE, Bonfanti A, Johnson P, Alzetani A, Conforti F, Doherty R, Lai CY, Johnson B, Bourdakos KN, Fletcher SV, Marshall BG, Jogai S, Brereton CJ, Chee SJ, Ottensmeier CH, Sime P, Gauldie J, Kolb M, Mahajan S, Fabre A, Bhaskar A, Jarolimek W, Richeldi L, O'Reilly KM, Monk PD, Thurner PJ, Davies DE.

Elife. 2018 Jul 3;7. pii: e36354. doi: 10.7554/eLife.36354.

3.

Epidemiology, Microbiological Diagnosis, and Clinical Outcomes in Pyogenic Vertebral Osteomyelitis: A 10-year Retrospective Cohort Study.

Chong BSW, Brereton CJ, Gordon A, Davis JS.

Open Forum Infect Dis. 2018 Mar 10;5(3):ofy037. doi: 10.1093/ofid/ofy037. eCollection 2018 Mar.

4.

Is gentamicin safe and effective for severe community-acquired pneumonia? An 8-year retrospective cohort study.

Brereton CJ, Lennon D, Browning S, Dunn E, Ferguson JK, Davis JS.

Int J Antimicrob Agents. 2018 Jun;51(6):862-866. doi: 10.1016/j.ijantimicag.2018.01.018. Epub 2018 May 18.

PMID:
29410326

Supplemental Content

Loading ...
Support Center